Trial Profile

A Phase I/II Study of Double Unit Umbilical Cord Blood (UCB) Transplantation Utilizing Graft Administration Via Intra-Bone Marrow Injection (Companion Protocol to MT2000-25).

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Immunosuppressants; Myeloablative agonists
Indications Acute myeloid leukaemia; B-cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Follicular lymphoma; Graft-versus-host disease; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; T-cell prolymphocytic leukaemia; Waldenstrom's macroglobulinaemia
Focus Therapeutic Use

28 Dec 2017 Biomarkers information updated
10 Sep 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
10 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com